Thrombin-induced cell proliferation and platelet-derived growth factor-AB release from A172 human glioblastoma cells

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 11, 2007, Pages 2219-2226

  Hayakawa, Y ^a   Kurimoto, M ^a   Nagai, S ^a   Kurosaki, K ^a   Tsuboi, Y ^a   Hamada, H ^a   Hayashi, N ^a   Endo, S ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Glioblastoma; Heparin cofactor II; Platelet derived growth factor; Protease activated receptor; Thrombin; Translational control

Indexed keywords

ADENOVIRUS VECTOR; HEPARIN COFACTOR II; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR AB; THROMBIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NERVE CELL CULTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; GLIOBLASTOMA; HEPARIN COFACTOR II; HUMANS; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-SIS; RNA, MESSENGER; THROMBIN;

EID: 35448988180     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02739.x     Document Type: Article

References (44)

1. Shuman MA. Thrombin-cellular interactions. Ann N Y Acad Sci 1986; 485: 228-39.
2. Kranzhofer R, Clinton SK, Ishii K, Coughlin SR, Fenton JW II, Libby P. Thrombin potency stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 1996; 79: 286-94.
3. LaMorte VJ, Kennedy ED, Collins LR, Goldstein D, Harootunian AT, Brown JH, Feramisco JR. A requirement for Ras protein function in thrombin-stimulated mitogenesis in astrocytoma cells. J Biol Chem 1993; 268: 19411-5.
4. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW II, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993; 91: 94-8.
5. Liu J, Schuff-Werner P, Steiner M. Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem Biophys Res Commun 2006; 343: 183-9.
6. Suidan HS, Stone SR, Hemmings BA, Monard D. Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 1992; 8: 363-75.
7. Gurwitz D, Cunningham D. Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 1988; 85: 3440-4.
8. Neveu I, Jehan F, Jandrot-Perrus M, Wion D, Brachet P. Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: A possible involvement of thrombin. J Neurochem 1993; 60: 858-67.
9. Perraud F, Besnard F, Sensenbrenner M, Labourdette G. Thrombin is a potent mitogen for rat astroblasts but not for oligodendroblasts and neuroblasts in primary culture. Int J Dev Neurosci 1987; 5: 181-8.
10. Loret C, Sensenbrenner M, Labourdette G. Differential phenotypic expression induced in cultured rat astroblasts by acidic fibroblast growth factor, epidermal growth factor and thrombin. J Biol Chem 1989; 264: 8319-27.
11. Lee KR, Betz AL, Kim S, Keep RF, Hoff JT. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir 1996; 138: 396-400.
12. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: The role of thrombin. J Neurosurg 1996; 84: 91-6.
13. Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Myers GM, Broderick JP, Brott TG, Hoff JT, Muizelaar JP. The role of blood clot formation on early edema development following experimental intracerebral hemorrhage. Stroke 1998; 29: 2580-6.
14. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999; 274: 23969-76.
15. Dihanich M, Kaser M, Reinhard E, Cunningham D, Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron 1991; 6: 575-81.
16. Hua Y, Tang L, Keep RF, Schallert T, Fewel ME, Muraszko KM, Hoff JT, Xi G. The role of thrombin in gliomas. J Thromb Haemost 2005; 3: 1917-23.
17. Ogiichi T, Hirashima Y, Nakamura S, Endo S, Kurimoto M, Takaku A. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation. J Neurooncol 2000; 46: 1-9.
18. Turgeon VL, Salman N, Houenou LJ. Thrombin: A neuronal cell modulator. Thromb Res 2000; 99: 417-27.
19. Tollefsen DM. Antithrombin deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2001: 4455-71.
20. Akai T, Niiya K, Sakuragawa N, Iizuka H, Endo S. Modulation of tissue-type plasminogen activator expression by platelet activating factor in human glioma cells. J Neurooncol 2002; 59: 193-8.
21. Hayakawa Y, Hirashima Y, Yamamoto H, Hayashi N, Kurimoto M, Kuwayama N, Endo S. Adenovirus-mediated expression of heparin cofactor II inhibits thrombin-induced cellular responses in fibroblasts and vascular smooth muscle cells. Thromb Res 2005; 116: 357-63.
22. Shimizu S, Gabazza EC, Hayashi T, Ido M, Adachi Y, Suzuki K. Thrombin stimulates the expression of PDGF in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: L503-10.
23. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
24. Dery O, Corvera CU, Steinhoff M, Bunnett NW. Protease-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol 1998; 273: C1429-52.
25. Coughlin SR. Thrombin signaling and protease-activated receptors. Nature 2000; 407: 258-64.
26. Faruqi TR, Weiss EJ, Shapiro MJ, Huang W, Coughlin SR. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J Biol Chem 2000; 275: 19728-34.
27. Grand RJA, Turnell AS, Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 1996; 313: 353-68.
28. Lidington EA, Steinberg R, Kinderlerer AR, Landis RC, Ohba M, Samarel A, Haskard DO, Mason JC. A role for proteinase-activated receptor 2 and PKC-ε in thrombin-mediated induction of decay-accelerating factor on human endothelial cells. Am J Physiol Cell Physiol 2005; 289: C1437-47.
29. Okamoto T, Nishibori M, Sawada K, Iwagaki H, Nakaya N, Jikuhara A, Tanaka N, Saeki K. The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma. J Neural Transm 2001; 108: 125-40.
30. Arisato T, Sarker KP, Kawahara K, Nakata M, Hashiguchi T, Osame M, Kitajima I, Maruyama I. The agonist of the protease-activated receptor-1 (PAR1) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human vascular smooth muscle cells. Cell Mol Life Sci 2003; 60: 1716-24.
31. Ryu J, Pyo H, Jou I, Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-κB. J Biol Chem 2000; 275: 29955-9.
32. Tran T, Stewart AG. Protease-activated receptor (PAR)-independent growth and pro-inflammatory actions of thrombin on human cultured airway smooth muscle. Br J Pharmacol 2003; 138: 865-75.
33. Lafleur MA, Hollenberg MD, Atkinson SJ, Knäuper V, Murphy G, Edwards DR. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species. Biochem J 2001; 357: 107-15.
34. Rossignol P, Bouton M-C, Jandrot-Perrus M, Bryckaert M, Jacob M-P, Bezeaud A, Guillin M-C, Michel J-B, Meilhac O. A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. Exp Cell Res 2004; 299: 279-85.
35. Taipale J, Koli K, Keski-Oja J. Release of transforming growth factor-ß1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 1992; 267: 25378-84.
36. Harsh GR, Keating MT, Escobedo JA, Williams LT. Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neurooncol 1990; 8: 1-12.
37. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M. Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992; 52: 3213-9.
38. Shih AH, Holland EC. Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 2006; 232: 139-47.
39. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc 2006; 81: 1241-57.
40. Rao CD, Pech M, Robbins KC, Aaronson SA. The 5′ untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor. Mol Cell Biol 1988; 8: 284-92.
41. Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 2004; 64: 4783-9.
42. Horvath P, Suganuma A, Inaba M, Pan Y-B, Gupta KC. Multiple elements in the 5′ untranslated region down-regulate c- sis messenger RNA translation. Cell Growth Differ 1995; 6: 1103-10.
43. Sella O, Gerlitz G, Le S-Y, Elroy-Stein O. Differentiation-induced internal translation of c- sis mRNA: Analysis of the cis elements and their differentiation-linked binding to the hnRNP C protein. Mol Cell Biol 1999; 19: 5429-40.
44. Wang D, Anderson JC, Gladson CL. The role of the extracellular matrix in angiogenesis in malignant glioma tumors. Brain Pathol 2005; 15: 318-26.